Literature DB >> 32734440

Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy.

Inge Van Hove1, Lies De Groef2, Bram Boeckx3,4, Elodie Modave3,4, Tjing-Tjing Hu1, Karen Beets1, Isabelle Etienne1, Tine Van Bergen1, Diether Lambrechts3,4, Lieve Moons2, Jean H M Feyen1, Michaël Porcu5.   

Abstract

AIMS/HYPOTHESIS: Diabetic retinopathy is a common complication of diabetes and a leading cause of visual impairment and blindness. Despite recent advances, our understanding of its pathophysiology remains incomplete. The aim of this study was to provide deeper insight into the complex network of molecular and cellular changes that underlie diabetic retinopathy by systematically mapping the transcriptional changes that occur in the different cellular compartments of the degenerating diabetic mouse retina.
METHODS: Single-cell RNA sequencing was performed on retinal tissue from 12-week-old wild-type and Akimba (Ins2Akita×Vegfa+/-) mice, which are known to replicate features of clinical diabetic retinopathy. This resulted in transcriptome data for 9474 retinal cells, which could be annotated to eight distinct retinal cell types. Using STRING analysis, we studied differentially expressed gene networks in neuronal, glial and immune cell compartments to create a comprehensive view on the pathological changes that occur in the Akimba retina. Using subclustering analysis, we further characterised macroglial and inflammatory cell subpopulations. Prominent findings were confirmed at the protein level using immunohistochemistry, western blotting and ELISA.
RESULTS: At 12 weeks, the Akimba retina was found to display degeneration of rod photoreceptors and presence of inflammatory cells, identified by subclustering analysis as monocyte, macrophage and microglial populations. Analysis of differentially expressed genes in the rod, cone, bipolar cell and macroglial compartments indicated changes in cell metabolism and ribosomal gene expression, gliosis, activation of immune system pathways and redox and metal ion dyshomeostasis. Experiments at the protein level supported a metabolic shift from glycolysis to oxidative phosphorylation (glyceraldehyde 3-phosphate dehydrogenase), activation of microglia/macrophages (isolectin-B4), metal ion and oxidative stress response (metallothionein and haem oxygenase-1) and reactive macroglia (glial fibrillary acidic protein and S100) in the Akimba retina, compared with wild-type mice. Our single-cell approach also indicates macroglial subpopulations with distinct fibrotic, inflammatory and gliotic profiles. CONCLUSIONS/
INTERPRETATION: Our study identifies molecular pathways underlying inflammatory, metabolic and oxidative stress-mediated changes in the Akimba mouse model of diabetic retinopathy and distinguishes distinct functional subtypes of inflammatory and macroglial cells. DATA AVAILABILITY: RNA-seq data have been deposited in the ArrayExpress database at EMBL-EBI ( www.ebi.ac.uk/arrayexpress ) under accession number E-MTAB-9061. Graphical abstract.

Entities:  

Keywords:  Akimba mouse; Diabetic retinopathy; Retina; Retinal degeneration; Single-cell transcriptomics

Year:  2020        PMID: 32734440     DOI: 10.1007/s00125-020-05218-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes.

Authors:  Qianyi Luo; Sameer P Leley; Erika Bello; Hurshdeep Dhami; Deepa Mathew; Ashay Dilip Bhatwadekar
Journal:  BMJ Open Diabetes Res Care       Date:  2022-05

Review 2.  The innate immune system in diabetic retinopathy.

Authors:  Warren W Pan; Feng Lin; Patrice E Fort
Journal:  Prog Retin Eye Res       Date:  2021-01-08       Impact factor: 19.704

3.  Secreted Phosphoprotein 1 Expression in Retinal Mononuclear Phagocytes Links Murine to Human Choroidal Neovascularization.

Authors:  Anja Schlecht; Peipei Zhang; Julian Wolf; Adrian Thien; Dennis-Dominik Rosmus; Stefaniya Boneva; Günther Schlunck; Clemens Lange; Peter Wieghofer
Journal:  Front Cell Dev Biol       Date:  2021-01-28

4.  The AppNL-G-F mouse retina is a site for preclinical Alzheimer's disease diagnosis and research.

Authors:  Marjan Vandenabeele; Lien Veys; Sophie Lemmens; Xavier Hadoux; Géraldine Gelders; Luca Masin; Lutgarde Serneels; Jan Theunis; Takashi Saito; Takaomi C Saido; Murali Jayapala; Patrick De Boever; Bart De Strooper; Ingeborg Stalmans; Peter van Wijngaarden; Lieve Moons; Lies De Groef
Journal:  Acta Neuropathol Commun       Date:  2021-01-06       Impact factor: 7.801

Review 5.  Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials.

Authors:  Vladimir Holan; Katerina Palacka; Barbora Hermankova
Journal:  Cells       Date:  2021-03-07       Impact factor: 6.600

Review 6.  Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.

Authors:  Binapani Mahaling; Shermaine W Y Low; Molly Beck; Devesh Kumar; Simrah Ahmed; Thomas B Connor; Baseer Ahmad; Shyam S Chaurasia
Journal:  Int J Mol Sci       Date:  2022-02-26       Impact factor: 5.923

Review 7.  The role of lipopolysaccharides in diabetic retinopathy.

Authors:  Xinran Qin; Haidong Zou
Journal:  BMC Ophthalmol       Date:  2022-02-22       Impact factor: 2.209

Review 8.  The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives.

Authors:  Dennis-Dominik Rosmus; Clemens Lange; Franziska Ludwig; Bahareh Ajami; Peter Wieghofer
Journal:  Biomedicines       Date:  2022-04-03

Review 9.  Microglia and Inflammatory Responses in Diabetic Retinopathy.

Authors:  Urbanus Muthai Kinuthia; Anne Wolf; Thomas Langmann
Journal:  Front Immunol       Date:  2020-11-06       Impact factor: 7.561

10.  Distinct Mechanisms of Human Retinal Endothelial Barrier Modulation In Vitro by Mediators of Diabetes and Uveitis.

Authors:  Madhuri Rudraraju; S Priya Narayanan; Payaningal R Somanath
Journal:  Life (Basel)       Date:  2021-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.